Related references
Note: Only part of the references are listed.A novel class of anthraquinone-based HDAC6 inhibitors
Yoojin Song et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
Alan P. Kozikowski et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class Ha histone deacetylase inhibitor
Christopher A. Luckhurst et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Design and biological evaluation of tetrahydro-beta-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors
Michel Leonhardt et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells
Yong Ling et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell Death
Yoshiyuki Hirata et al.
SCIENTIFIC REPORTS (2018)
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies
Margherita Brindisi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
Nicholas J. Porter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
HDAC6 Brain Mapping with [18F] Bavarostat Enabled by a RuMediated Deoxyfluorination
Martin G. Strebl et al.
ACS CENTRAL SCIENCE (2017)
Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach
Kai-Cheng Hsu et al.
SCIENTIFIC REPORTS (2017)
Histone/protein deacetylase 11 targeting promotes Foxp3+Treg function
Jianbing Huang et al.
SCIENTIFIC REPORTS (2017)
Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class Ila Histone Deacetylase (HDAC) Inhibitors
Christopher A. Luckhurst et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Dissecting structure-activity-relationships of crebinostat: Brain penetrant HDAC inhibitors for neuroepigenetic regulation
Balaram Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta
Michalina Hebda et al.
MOLECULES (2016)
A High Affinity Red Fluorescence and Colorimetric Probe for Amyloid β Aggregates
K. Rajasekhar et al.
SCIENTIFIC REPORTS (2016)
A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors
Laura Goracci et al.
SCIENTIFIC REPORTS (2016)
Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
Xianping Lu et al.
INTRACTABLE & RARE DISEASES RESEARCH (2016)
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Hyon-Zu Lee et al.
CLINICAL CANCER RESEARCH (2015)
Significant facilitation of metal-free aerobic oxidative cyclization of imines with water in synthesis of benzimidazoles
Ye-Sol Lee et al.
TETRAHEDRON (2015)
An HDAC-dependent epigenetic mechanism that enhances the efficacy of the antidepressant drug fluoxetine
C. Schmauss
SCIENTIFIC REPORTS (2015)
Image-Guided Synthesis Reveals Potent Blood-Brain Barrier Permeable Histone Deacetylase Inhibitors
Young Jun Seo et al.
ACS CHEMICAL NEUROSCIENCE (2014)
PET Imaging Demonstrates Histone Deacetylase Target Engagement and Clarifies Brain Penetrance of Known and Novel Small Molecule Inhibitors in Rat
F. A. Schroeder et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Benzothiazoles: How Relevant in Cancer Drug Design Strategy?
Meenakshi Singh et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
Jeanine Jochems et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Amyloid-β probes: Review of structure-activity and brain-kinetics relationships
Todd J. Eckroat et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2013)
Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET
Sung Won Kim et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition
Jesse E. Hanson et al.
PLOS ONE (2013)
HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
Melissa Malvaez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cyanide as a powerful catalyst for facile synthesis of benzofused heteroaromatic compounds via aerobic oxidation
Yeon-Ho Cho et al.
TETRAHEDRON (2013)
Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives as Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological Evaluation
Pu Xiang et al.
MOLECULES (2012)
Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
Karen M. VanderMolen et al.
JOURNAL OF ANTIBIOTICS (2011)
Histone Deacetylase Inhibitor MS-275 Exhibits Poor Brain Penetration: Pharmacokinetic Studies of [C-11]MS-275 using Positron Emission Tomography
Jacob M. Hooker et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Small organic probes as amyloid specific ligands - Past and recent molecular scaffolds
K. Peter R. Nilsson
FEBS LETTERS (2009)
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Aleksey G. Kazantsev et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma, (CTCL)
Madeleine Duvic et al.
BLOOD (2007)
Structure-brain exposure relationships
Stephen A. Hitchcock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Facile and efficient One-pot protocol for the synthesis of benzoxazole and benzothiazole derivatives using molecular iodine as catalyst
Firouz Matloubi Moghaddam et al.
SYNTHETIC COMMUNICATIONS (2006)
Acetylation and deacetylation of non-histone proteins
MA Glozak et al.
GENE (2005)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Share Paper
